Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001558370-16-007797
Filing Date
2016-08-09
Accepted
2016-08-09 16:09:46
Documents
9
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A axsm-20151231x10ka.htm 10-K/A 2378715
2 EX-23.1 axsm-20151231ex231ad9d06.htm EX-23.1 7426
3 EX-31.1 axsm-20151231ex3111c380e.htm EX-31.1 14618
4 EX-31.2 axsm-20151231ex3124cf583.htm EX-31.2 14029
5 EX-32.1 axsm-20151231ex3219f3415.htm EX-32.1 7641
6 EX-32.2 axsm-20151231ex32245e82a.htm EX-32.2 7612
7 GRAPHIC axsm20151231x10ka001.jpg GRAPHIC 177577
8 GRAPHIC axsm20151231x10ka002.jpg GRAPHIC 28962
9 GRAPHIC axsm20151231x10ka003.jpg GRAPHIC 49698
  Complete submission text file 0001558370-16-007797.txt   2784242
Mailing Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004
Business Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004 212-203-5072
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37635 | Film No.: 161817981
SIC: 2834 Pharmaceutical Preparations